// App-Quantinova.ai

E038 : A common measure of the impact of glucocorticoids in patients with inflammatory and autoimmune conditions - the Steroid PRO: A cross-cultural validation study with Rasch models

Researchers

Presenter

  • Susan Bridgewater

Principal Investigators

  • Mwidimi Ndosi

  • Jill Dawson

  • Pamela Richards

  • Christine Silverthorne

  • Emma Dures

  • Susan Goodman

  • Catherine Hill

  • Sarah L Mackie

  • Joanna C Robson

Medical Centers

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK

  • Academic Rheumatology, University Hospitals Bristol NHS Foundation Trust, Bristol, UNITED KINGDOM

  • School of Medicine, University of Adelaide, Adelaide, Australia

  • NIHR Leeds Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

  • Faculty of Health and Life Sciences, University of the West of England, Bristol, United Kingdom

  • Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia

  • Nuffield Department of Population Health HSRU, University of Oxford, Oxford, United Kingdom

  • Division of Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY

Locations

  • United Kingdom

  • Australia

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Glucocorticoid

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved